Experian tops FY26 forecasts, sets new $1 bln share buyback

Experian reported record full-year revenue of $8.45 billion, up 12% at actual exchange rates, with Benchmark EPS rising 15% to 179.8 cents and EBIT increasing 15% to $2.41 billion. The company also announced a new $1 billion share repurchase programme through June 30, 2027, after $725 million of buybacks in fiscal 2026, and lifted its full-year dividend 11% to 69.25 cents per share. Fiscal 2027 guidance calls for 6-8% organic revenue growth, 8-11% total revenue growth, and double-digit Benchmark EPS growth, though the 7% midpoint is slightly below consensus.

Analysis

The market should treat this as a quality-compounding signal rather than a simple beat-and-raise. The combination of sustained mid-to-high single-digit organic growth, margin expansion, and a renewed buyback suggests management sees no imminent demand deceleration, and that matters because the stock’s multiple is likely being underpinned more by durability than by near-term upside to EPS. The fact that guidance midpoint looks a touch softer than consensus is less important than the implied resilience in a harder macro backdrop; this is the kind of print that tends to compress the discount rate on a business over several quarters, not days.

The second-order effect is on competitors that lack the same scale in bureau data, analytics, and cross-sell. A stronger capital return framework can force a valuation gap: the winners are the platforms with high recurring revenue and low incremental capital intensity, while smaller/regional data vendors may struggle to match repurchase capacity without sacrificing growth spend. In practical terms, this can widen share among enterprise customers who prefer a financially disciplined vendor, especially if procurement teams interpret the performance as evidence of product stickiness and lower execution risk.

The main risk is that the market extrapolates too aggressively into FY27 when interest expense is rising and growth is still uneven by geography. If North America normalizes even modestly over the next 2-3 quarters, the stock can give back gains quickly because the re-rating case is built on consistency, not cyclicality. The contrarian read is that consensus may be over-anchored to headline growth while underestimating how much of the earnings leverage is already consumed by buybacks and margin gains; upside from here is likely slower and more multiple-driven than the current narrative implies.

Key Decisions for Investors

• Long EXPERIAN-like compounders vs. lower-quality data/services names: go long data/recurring-revenue leaders and short a basket of weaker analytics/outsourced processing peers over the next 3-6 months; target 10-15% relative outperformance if the market continues rewarding capital-efficient growth.
• Buy the dip in the stock on any 2-3% post-earnings pullback, with a 6-12 month horizon; the buyback plus dividend support should cap downside unless organic growth meaningfully slows.
• Use call spreads rather than outright long stock for the next 2 quarters: upside is likely incremental, so a 1x2 or bull call spread offers better risk/reward if the market takes the guidance as modestly conservative.
• Watch for any consensus drift in the next sell-side refresh cycle; if estimates do not fall despite the softer growth midpoint, consider a tactical short against the move into the next quarter, because the stock may have already priced in the cash-return story.